Gene therapy of uterine leiomyomas

Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice

Ayman Al-Hendy, Eun J. Lee, Hui Q. Wang, John A. Copland

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Leiomyomas (fibroids) are common estrogen-dependent uterine tumors with no effective medicinal treatment; hysterectomy is the mainstay of management. This study was undertaken to investigate a potential therapy for leiomyoma; we used a mutated dominant-negative estrogen receptor gene delivered via an adenoviral vector (Ad-ER-DN). Ad-ER-DN transduction, in both human and rat leiomyoma cell lines, induced an increase in both caspase-3 levels and BAX/Bcl-2 ratio with evident apoptosis in the TdT-mediated dUTP nick-end labeling assay. In nude mice, rat leiomyoma cells ex vivo transduced with Ad-ER-DN supported significantly smaller tumors compared with Ad-LacZ-treated cells 5 weeks after implantation. In mice treated by direct intratumor injection into preexisting lesions, Ad-ER-DN caused immediate overall arrest of tumor growth. The Ad-ER-DN-treated tumors demonstrated severely inhibited cell proliferation (BrdU index) and a marked increase in the number of apoptotic cells (TdT-mediated dUTP nick-end labeling index). Dominant-negative estrogen receptor gene therapy may provide a nonsurgical treatment option for women with symptomatic uterine fibroids who want to preserve their uteri.

Original languageEnglish (US)
Pages (from-to)1621-1631
Number of pages11
JournalAmerican Journal of Obstetrics and Gynecology
Volume191
Issue number5
DOIs
StatePublished - Nov 1 2004

Fingerprint

Leiomyoma
Adenoviridae
Nude Mice
Estrogen Receptors
Genetic Therapy
Growth
Neoplasms
Nude Rats
Bromodeoxyuridine
Hysterectomy
Caspase 3
Uterus
Estrogens
Therapeutics
Cell Count
Cell Proliferation
Apoptosis
Cell Line
Injections
Genes

Keywords

  • Dominant-negative estrogen receptor
  • Gene therapy
  • Leiomyomas

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Gene therapy of uterine leiomyomas : Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. / Al-Hendy, Ayman; Lee, Eun J.; Wang, Hui Q.; Copland, John A.

In: American Journal of Obstetrics and Gynecology, Vol. 191, No. 5, 01.11.2004, p. 1621-1631.

Research output: Contribution to journalArticle

@article{a8c6370af2414e1397fcdf38aebdcf17,
title = "Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice",
abstract = "Leiomyomas (fibroids) are common estrogen-dependent uterine tumors with no effective medicinal treatment; hysterectomy is the mainstay of management. This study was undertaken to investigate a potential therapy for leiomyoma; we used a mutated dominant-negative estrogen receptor gene delivered via an adenoviral vector (Ad-ER-DN). Ad-ER-DN transduction, in both human and rat leiomyoma cell lines, induced an increase in both caspase-3 levels and BAX/Bcl-2 ratio with evident apoptosis in the TdT-mediated dUTP nick-end labeling assay. In nude mice, rat leiomyoma cells ex vivo transduced with Ad-ER-DN supported significantly smaller tumors compared with Ad-LacZ-treated cells 5 weeks after implantation. In mice treated by direct intratumor injection into preexisting lesions, Ad-ER-DN caused immediate overall arrest of tumor growth. The Ad-ER-DN-treated tumors demonstrated severely inhibited cell proliferation (BrdU index) and a marked increase in the number of apoptotic cells (TdT-mediated dUTP nick-end labeling index). Dominant-negative estrogen receptor gene therapy may provide a nonsurgical treatment option for women with symptomatic uterine fibroids who want to preserve their uteri.",
keywords = "Dominant-negative estrogen receptor, Gene therapy, Leiomyomas",
author = "Ayman Al-Hendy and Lee, {Eun J.} and Wang, {Hui Q.} and Copland, {John A.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1016/j.ajog.2004.04.022",
language = "English (US)",
volume = "191",
pages = "1621--1631",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Gene therapy of uterine leiomyomas

T2 - Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice

AU - Al-Hendy, Ayman

AU - Lee, Eun J.

AU - Wang, Hui Q.

AU - Copland, John A.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Leiomyomas (fibroids) are common estrogen-dependent uterine tumors with no effective medicinal treatment; hysterectomy is the mainstay of management. This study was undertaken to investigate a potential therapy for leiomyoma; we used a mutated dominant-negative estrogen receptor gene delivered via an adenoviral vector (Ad-ER-DN). Ad-ER-DN transduction, in both human and rat leiomyoma cell lines, induced an increase in both caspase-3 levels and BAX/Bcl-2 ratio with evident apoptosis in the TdT-mediated dUTP nick-end labeling assay. In nude mice, rat leiomyoma cells ex vivo transduced with Ad-ER-DN supported significantly smaller tumors compared with Ad-LacZ-treated cells 5 weeks after implantation. In mice treated by direct intratumor injection into preexisting lesions, Ad-ER-DN caused immediate overall arrest of tumor growth. The Ad-ER-DN-treated tumors demonstrated severely inhibited cell proliferation (BrdU index) and a marked increase in the number of apoptotic cells (TdT-mediated dUTP nick-end labeling index). Dominant-negative estrogen receptor gene therapy may provide a nonsurgical treatment option for women with symptomatic uterine fibroids who want to preserve their uteri.

AB - Leiomyomas (fibroids) are common estrogen-dependent uterine tumors with no effective medicinal treatment; hysterectomy is the mainstay of management. This study was undertaken to investigate a potential therapy for leiomyoma; we used a mutated dominant-negative estrogen receptor gene delivered via an adenoviral vector (Ad-ER-DN). Ad-ER-DN transduction, in both human and rat leiomyoma cell lines, induced an increase in both caspase-3 levels and BAX/Bcl-2 ratio with evident apoptosis in the TdT-mediated dUTP nick-end labeling assay. In nude mice, rat leiomyoma cells ex vivo transduced with Ad-ER-DN supported significantly smaller tumors compared with Ad-LacZ-treated cells 5 weeks after implantation. In mice treated by direct intratumor injection into preexisting lesions, Ad-ER-DN caused immediate overall arrest of tumor growth. The Ad-ER-DN-treated tumors demonstrated severely inhibited cell proliferation (BrdU index) and a marked increase in the number of apoptotic cells (TdT-mediated dUTP nick-end labeling index). Dominant-negative estrogen receptor gene therapy may provide a nonsurgical treatment option for women with symptomatic uterine fibroids who want to preserve their uteri.

KW - Dominant-negative estrogen receptor

KW - Gene therapy

KW - Leiomyomas

UR - http://www.scopus.com/inward/record.url?scp=8544251273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544251273&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2004.04.022

DO - 10.1016/j.ajog.2004.04.022

M3 - Article

VL - 191

SP - 1621

EP - 1631

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -